Translation of "Mesures dépourvues d'effet obligatoire " (French → English) :

(iii)written evidence based on the regulatory technical standards developed by ESMA that the relevant third country law provides for a rule equivalent to the provisions for which compliance is impossible, which has the same regulatory purpose and offers the same level of protection to the investors of the relevant AIFs and that the AIFM complies with that equivalent rule; such written evidence being supported by a legal opinion on the existence of the relevant incompatible mandatory provision in the law of the third country and including a description of the regulatory purpose and the nature of the investor protection pursued by it; an ...[+++]d

written evidence based on the regulatory technical standards developed by ESMA that the relevant third country law provides for a rule equivalent to the provisions for which compliance is impossible, which has the same regulatory purpose and offers the same level of protection to the investors of the relevant AIFs and that the AIFM complies with that equivalent rule; such written evidence being supported by a legal opinion on the existence of the relevant incompatible mandatory provision in the law of the third country and including a description of the regulatory purpose and the nature of the investor protection pursued by it; and

(Return tabled) Question No. 864 Ms. Kirsty Duncan: With respect to mental health and suicide in the Canadian Forces (CF), including regular forces, reservists and veterans, as well as among Royal Canadian Mounted Police (RCMP) veterans: (a) what does history and research show from the First World War (WWI) and the Second World War (WWII), regarding the percentage of Canadian veterans who suffered some degree of Post Traumatic Stress Disorder (PTSD) and how it might have impacted their ability to (i) hold down jobs, (ii) maintain relationships, (iii) overcome substance abuse, (iv) maintain their will to live; (b) how are suicides tracked for CF regular forces, reservists and veterans, including RCMP veterans, (i) has the tracking method ch ...[+++]anged over time (from 2000 onwards) for any of these groups, including name changes (e.g., suicide versus sudden death) and, if so, how, why and when, (ii) how are suicides tracked among veterans who may not be known to Veterans Affairs Canada (VAC) and who may be under other types of care (e.g., in hospitals) or in homeless shelters, prisons, etc.; (c) what are the identified gaps in tracking for each of the identified groups and, for each gap, what action items (i) are planned (including predicted start and completion dates, and necessary funding), (ii) are being implemented (including predicted completion date and necessary funding), (iii) have been completed to address the problem; (d) how are suicides investigated for each identified group today and, for each group, for the years 1990 to the present (or years available), (i) what percentage of victims were known to either the Department of National Defense (DND) or VAC prior to the suicide, or to the medical, social-aid or prison system, (ii) what percentage had attempted suicide before, (iii) what percentage suffered from an identified Operational Stress Injury (OSI), including PTSD, anxiety, depression or substance abuse, (iv) what percentage suffered from acquired brain ...

Although that has political weight, it has no binding effect whatever.

Cummins: With regard to the mandatory use of mefloquine by Canadian forces personnel, (a) what clinical or field studies did the Department of National Defence undertake or fund into the possible adverse effects including the impairment of judgment of the mandatory use of mefloquine by Canadian forces while in Somalia, both while the personnel were in Somalia and on their return to Canada, (b) what clinical or field studies did the Department of National Defence undertake or fund into the possible adverse effects including the impairm ...[+++]ent of judgment of the mandatory use of mefloquine by Canadian forces while in Rwanda, both while the personnel were in Rwanda and on their return to Canada, (c) what amount of alcohol was available on a daily basis to Canadian forces personnel in Somalia and later in Rwanda who had received the mandatory dosage of mefloquine, what adjustments or precautions were made to the dosages by those administering the drug and what advice was given to persons required to take mefloquine who might be expected to use alcohol during their tour of duty, (d) what screening and other precautions were taken by those administering mefloquine, and what advice was given to Canadian forces personnel in regard to self-administered recreational body building, locally grown stimulants and other such drugs that it could reasonably be expected that personnel might be taking concurrent to their usage of mefloquine, (e) what ranks and occupations in the Canadian forces were not subject to the mandatory use of mefloquine in either Somalia or Rwanda and why were they not subject to the mandatory requirement to take mefloquine and (f) why is the effective dosage of mefloquine taken by Canadian forces stronger than the equivalent dosage given U.S. military personnel and what are the possible adverse effects of such stronger dosages?

While it puts a process in place, nothing within this process is binding on a contracting party or prevents unilateral action that could seriously jeopardize conservation.